PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
26461093-3	2015	We found that an epigenetic pathway involving MLL2 is crucial for growth of HER2(+) cells and MLL2 reduces sensitivity of the cancer cells to a HER2 inhibitor, lapatinib.	Lapatinib	160-169	lysine methyltransferase 2D	Homo sapiens	46-50	
26461093-3	2015	We found that an epigenetic pathway involving MLL2 is crucial for growth of HER2(+) cells and MLL2 reduces sensitivity of the cancer cells to a HER2 inhibitor, lapatinib.	Lapatinib	160-169	lysine methyltransferase 2D	Homo sapiens	94-98	
26461093-4	2015	Lapatinib-induced FOXO transcription factors, normally tumor-suppressing, paradoxically upregulate c-Myc epigenetically in concert with a cascade of MLL2-associating epigenetic regulators to dampen sensitivity of the cancer cells to lapatinib.	Lapatinib	0-9	lysine methyltransferase 2D	Homo sapiens	149-153	
26461093-4	2015	Lapatinib-induced FOXO transcription factors, normally tumor-suppressing, paradoxically upregulate c-Myc epigenetically in concert with a cascade of MLL2-associating epigenetic regulators to dampen sensitivity of the cancer cells to lapatinib.	Lapatinib	233-242	lysine methyltransferase 2D	Homo sapiens	149-153